A33 Behavioural evaluation of Huntington's disease mouse models with an automated home cage system

Magg, J; Portal, E; Kelp, A; Ehrismann, J; Pahnke, G; Riess, O; Nguyen, H P
September 2010
Journal of Neurology, Neurosurgery & Psychiatry;Sep2010 Supp, Vol. 81, pA11
Academic Journal
Huntington's disease (HD) is a neurodegenerative disease and is caused by an expanded trinucleotide repeat in the huntingtin gene. There are various animal models of HD which all mirror at least partially the behavioural and neuropathological phenotype of the human disease. Nevertheless, the results of the studies in HD animal models are inconsistent across laboratories because of the lack of standardised testing conditions and husbandry and the autotelic differences between the different lines. To avoid experimenter dependent effects in the behavioural evaluation of HD mice we have compared the YAC128 full length model (on a FVB/N background) and the Hdh Q111 knock-in mouse (on a C57Bl/6 background) with heterozygous HDHex4/5 knock-out mice using an automated home cage system at different ages. The Labmaster system measured automatically and in a standardised setting drinking, feeding and activity for a time period of 70 h. Therefore, it allows us to detect even subtle differences in circadian food and fluid consumption as well as locomotor activity with rearing behaviour. This is especially of importance in the ‘late onset’ full length models with a relatively mild and not rapidly progressive phenotype. Furthermore, it has been shown that expression levels of full length htt influence body weight in a dose dependent manner in YAC128, YAC18 and heterozygous Hdh knock-out mice. Our study gives us the opportunity to carefully characterise the relationship between different levels of htt and activity and food intake in vivo. First results will be presented.


Related Articles

  • New insight into the cellular defects in Huntington's disease.  // Biomedical Market Newsletter;10/10/2011, Vol. 21, p87 

    The article focuses on the findings of researchers regarding the function of normal Htt protein which is interrupted in Huntington's disease using a mouse model.

  • A Flexible Estimating Equations Approach for Mapping Function-Valued Traits. Hao Xiong; Goulding, Evan H.; Carlson, Elaine J.; Tecott, Laurence H.; McCulloch, Charles E.; Sen, aŚaunak // Genetics;Sep2011, Vol. 189 Issue 1, p305 

    The article proposes an alternative framework for mapping function-valued traits based on estimating equations. An automated home cage monitoring system was used in a genetic analysis of mouse behavior. It notes that a regression model can be employed in expressing the trait data. It cites the...

  • Huntington unit tests 911 system for ATMs. Piskora, Beth // American Banker;5/11/1995, Vol. 160 Issue 90, p15 

    Reports on Huntington National Bank's evaluation of the SafeAlert, a 911 emergency communications system installed in automated tellers.

  • Elgato Eve.  // Computer Act!ve;11/11/2015, Issue 462, p24 

    The article evaluates the Elgato Eve home automation system.

  • In reverse gear. Bates, Gillian // Nature;4/27/2000, Vol. 404 Issue 6781, p944 

    Reports on Yamamoto and colleagues' mouse model of Huntington's disease wherein the pathological features and symptoms of the disease can be reversed. Alterations in the HD gene; Progression and reversal of Hungtington's disease in the model; Implications for the treatment of the disease in humans.

  • Neurodegenerative disease: A good night's sleep. Whalley, Katherine // Nature Reviews Neuroscience;Sep2007, Vol. 8 Issue 9, p656 

    The article explores the study "Pharmacological Imposition of Sleep Slows Cognitive Decline and Reverses Dysregulation of Circadian Gene Expression in a Transgenic Mouse Model of Huntington's Disease," by P. N. Pallier and colleagues. In this paper, researchers demonstrate that the cognitive...

  • Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease. Chen, Minghua; Ona, Victor O.; Li, Mingwei; Ferrante, Robert J.; Fink, Klaus B.; Zhu, Shan; Bian, Jie; Guo, Lei; Farrell, Laurie A.; Hersch, Steve M.; Hobbs, Wendy; Vonsattel, Jean-Paul; Cha, Jang-Ho J.; Friedlander, Robert M. // Nature Medicine;Jul2000, Vol. 6 Issue 7, p797 

    Huntington disease is an autosomal dominant neurodegenerative disease with no effective treatment. Minocycline is a tetracycline derivative with proven safety. After ischemia, minocycline inhibits caspase-1 and inducible nitric oxide synthetase upregulation, and reduces infarction. As caspase-1...

  • Inactivation of Hdh in the brain and testis results in progressive neurodegeneration and sterility in mice. Dragatsis, Ioannis; Levine, Michael S.; Zeitlin, Scott // Nature Genetics;Nov2000, Vol. 26 Issue 3, p300 

    Inactivation of the mouse homologue of the Huntington disease gene (Hdh) results in early embryonic lethality. To investigate the normal function of Hdh in the adult and to evaluate current models for Huntington disease (HD), we have used the Cre/loxP site-specific recombination strategy to...

  • Sweet relief for Huntington disease. Katsuno, Masahisa; Adachi, Hiroaki; Sobue, Gen // Nature Medicine;Feb2004, Vol. 10 Issue 2, p123 

    This article reports that in mouse models of Huntington's disease, treatment with a non-toxic sugar substance can prevent the development of the brain pathology associated with Huntington's disease, and can delay the progress of symptoms such as motor dysfunction. The approach stands out as the...


Read the Article


Sign out of this library

Other Topics